RxDoctor Payments Data

Stuart Ditchek

General Practice · Brooklyn, NYNPI 1528068103

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $137,257 of the $170,990 with a category attached, or 80.3%. Sanofi accounts for 99.8% of it on its own, with 4 other manufacturers making up the rest. Among general practice clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$170,990in general payments, 2019–2025

Across 180 payments — averaging $949.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$171K
  • GSK$210
  • Sanofi Pasteur Inc.$75
  • Pfizer$22
  • Alk-abello, Inc$17

What the payments were for

  • Speaking & faculty fees$137,25780%
  • Travel & lodging$29,76717%
  • Food & beverage$3,9652%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi162$170,666
GSK12$210
Sanofi Pasteur Inc.4$75
Pfizer1$22
Alk-abello, Inc1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$170,990 in reported general payments places this provider in the 95th percentile of 5,764 general practice providers in New York.

See all general practice providers in New York

Other general practice in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →